Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Pardis Sabeti
Broad Institute, Inc., Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sherlock Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Sherlock Biosciences is a private company formed to develop diagnostic. The Company’s goal is to address significant unmet needs in infectious disease, oncology, agriculture, and other areas to transform diagnostic testing and global public health. Sherlock is using engineering biology tools, including CRISPR and synthetic biology to develop a new generation of diagnostics. The research project aims to develop new diagnostic tools. As such the outcomes of the research may be meaningful or of interest to the company.
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
Our limited knowledge of the individual organisms responsible for infectious diseases, and the way they interact with the hosts they infect, and the insects that transmit them, prevents us from better managing the staggering global burden of these diseases. We will focus on defining the genes and genomes of these organisms, and how these genes influence disease and drug resistance. We will use collaborative approaches and powerful new laboratory and analytical techniques to study diseases caused by viruses, bacteria, fungi and parasites to develop new ways to diagnose, prevent and treat them.
Filed on May 22, 2019.
Tell us what you know about Pardis Sabeti's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Pardis Sabeti”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Pardis Sabeti | Broad Institute, Inc. | Conflict of Interest | Sherlock Biosciences | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.